Kyriaco at a 20 cents share price it’s a 32 million dollar valuation lol. Peers in the TBI space are already trading multiples of this on safety north of 100 million dollars. It’s got a lot to rerate now it has the potential to overtake a 4 billion dollar market on cardiovascular health.
Ann: NYR Completes Safety Studies Ahead of Phase I Clinical Trial, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
-0.020(5.71%) |
Mkt cap ! $70.65M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 35.5¢ | 31.0¢ | $182.8K | 553.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 32775 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 13443 | 2 |
View Market Depth
| Last trade - 12.53pm 23/07/2025 (20 minute delay) ? |
| NYR (ASX) Chart |